WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer

WEE1 Dependency and Pejorative Prognostic Value in Triple‐Negative Breast Cancer

Bibliographic Details
Main Authors:	Alexandre deNonneville, Pascal Finetti, Daniel Birnbaum, Emilie Mamessier, François Bertucci
Format:	Article
Language:	English
Published:	Wiley 2021-09-01
Series:	Advanced Science
Subjects:	cell cycle expression survival triple‐negative breast cancer WEE1
Online Access:	https://doi.org/10.1002/advs.202101030

Similar Items

CISH Expression Is Associated with Metastasis-Free Interval in Triple-Negative Breast Cancer and Refines the Prognostic Value of PDL1 Expression
by: Laurys Boudin, et al.
Published: (2022-07-01)

Wee1 Inhibition Enhances the Anti-Tumor Effects of Capecitabine in Preclinical Models of Triple-Negative Breast Cancer
by: Todd M. Pitts, et al.
Published: (2020-03-01)

A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers
by: Alexandre de Nonneville, et al.
Published: (2019-08-01)

Wee1 Kinase: A Potential Target to Overcome Tumor Resistance to Therapy
by: Francesca Esposito, et al.
Published: (2021-10-01)

A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
by: Andrea Ghelli Luserna di Rorà, et al.
Published: (2020-09-01)

Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia
by: Marco Santoro, et al.
Published: (2022-08-01)

LncRNA WEE2-AS1 is a diagnostic biomarker that predicts poor prognoses in patients with glioma
by: Xuqiang Zhu, et al.
Published: (2023-02-01)

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer
by: François Bertucci, et al.
Published: (2023-08-01)

Triple-Negative Breast Cancer Survival in Iranian Patients
by: Mahdi Aghili, et al.
Published: (2013-08-01)

Acquired small cell lung cancer resistance to Chk1 inhibitors involves Wee1 up‐regulation
by: Xiaoliang Zhao, et al.
Published: (2021-04-01)

Discovery of potential WEE1 inhibitors via hybrid virtual screening
by: Tingting Jin, et al.
Published: (2023-12-01)

Validation and comparison of the molecular classifications of pancreatic carcinomas
by: David J. Birnbaum, et al.
Published: (2017-11-01)

Prognostic and Predictive Value of <i>LIV1</i> Expression in Early Breast Cancer and by Molecular Subtype
by: Alexandre de Nonneville, et al.
Published: (2023-03-01)

Head and Body/Tail Pancreatic Carcinomas Are Not the Same Tumors
by: David Jérémie Birnbaum, et al.
Published: (2019-04-01)

The Outcome of Patients with Triple Negative Breast Cancer: The Turkish Oncology Group Experience
by: Yeşim Eralp, et al.
Published: (2014-10-01)

The Prognostic and Therapeutic Implications of the Chemoresistance Gene BIRC5 in Triple-Negative Breast Cancer
by: Getinet M. Adinew, et al.
Published: (2022-10-01)

Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
by: Xiang Song, et al.
Published: (2019-09-01)

Prognostic Significance of CCNB2 Expression in Triple-Negative Breast Cancer
by: Cao J, et al.
Published: (2021-12-01)

PDL1 expression is associated with longer postoperative, survival in adrenocortical carcinoma
by: Emilien Billon, et al.
Published: (2019-11-01)

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
by: Santosh K. Dasari, et al.
Published: (2023-02-01)

Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR
by: Wenwen Chien, et al.
Published: (2023-04-01)

A prognostic model for triple-negative breast cancer patients with liver metastasis: A population-based study
by: Liguo Zhang, et al.
Published: (2024-04-01)

The therapeutic and prognostic role of cuproptosis-related genes in triple negative breast cancer
by: Bingye Shi, et al.
Published: (2023-05-01)

Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1
by: Amirali B. Bukhari, et al.
Published: (2022-02-01)

The MonarchE trial: improving the clinical outcome in HR+/HER2− early breast cancer: recent results and next steps
by: François Bertucci, et al.
Published: (2023-08-01)

Fission yeast Wee1 is required for stable kinetochore-microtubule attachment
by: Masahiro Takado, et al.
Published: (2024-01-01)

Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
by: Yi Yao, et al.
Published: (2019-02-01)

Novel insights into maintaining genomic integrity: Wee1 regulating Mus81/Eme1
by: Martín Yusé, et al.
Published: (2011-12-01)

Inhibition of WEE1 Suppresses the Tumor Growth in Laryngeal Squamous Cell Carcinoma
by: Meng-Ling Yuan, et al.
Published: (2018-09-01)

Regulation of G2/M Transition by Inhibition of WEE1 and PKMYT1 Kinases
by: Matthias Schmidt, et al.
Published: (2017-11-01)

Prognostic Factors and Models for Elderly (≥70 Years Old) Primary Operable Triple-Negative Breast Cancer: Analysis From the National Cancer Database
by: Zhuowei Tang, et al.
Published: (2022-03-01)

Clinical Candidates Targeting the ATR–CHK1–WEE1 Axis in Cancer
by: Lukas Gorecki, et al.
Published: (2021-02-01)

Trophoblast cell-surface antigen 2 (TROP2) expression in triple-negative breast cancer
by: Yeonjin Jeon, et al.
Published: (2022-09-01)

WEE1 and PARP-1 play critical roles in myelodysplastic syndrome and acute myeloid leukemia treatment
by: Seiichi Okabe, et al.
Published: (2023-06-01)

Inhibiting WEE1 Augments the Antitumor Efficacy of Cisplatin in Urothelial Carcinoma by Enhancing the DNA Damage Process
by: Yu-Li Su, et al.
Published: (2023-05-01)

Capn3 depletion causes Chk1 and Wee1 accumulation and disrupts synchronization of cell cycle reentry during liver regeneration after partial hepatectomy
by: Feng Chen, et al.
Published: (2020-06-01)

Treatment-associated survival outcomes in real-world patients with de novo metastatic triple-negative breast cancer: Age as a significant treatment effect-modifier
by: Wei-Pang Chung, et al.
Published: (2022-01-01)

Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption
by: Zahran AM, et al.
Published: (2021-08-01)

Caffeine Stabilises Fission Yeast Wee1 in a Rad24-Dependent Manner but Attenuates Its Expression in Response to DNA Damage
by: John P. Alao, et al.
Published: (2020-09-01)

Impaired DNA double-strand break repair and effective radiosensitization of HPV-negative HNSCC cell lines through combined inhibition of PARP and Wee1
by: Agnes Oetting, et al.
Published: (2023-07-01)